Differential expression of genes in co-cultured versus separately cultured fibroblasts and epithelial cells from human benign hyperplastic prostate tissues

International Journal of Molecular Medicine

Volumn 26, Issue 1, 2010, Pages 17-25

  Yang, Xiaoli ^a   Xuan, Qiang ^a   Mo, Linjian ^a   Huang, Fengyu ^a   Pang, Youhong ^a   He, Min ^a   Lin, Weixiong ^a   Li, Qingdi Quentin ^b   Mo, Zengnan ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Benign prostatic hyperplasia; Differential expression; Epithelia; Epithelial stromal interaction; Fibroblasts; Kallikrein

Indexed keywords

CALCIUM BINDING PROTEIN; CELL ANTIGEN; COLLAGEN TYPE 1; COPPER ZINC SUPEROXIDE DISMUTASE; CYCLIN I; CYCLINE; KALLIKREIN; LATEXIN; MESSENGER RNA; NEDD8 PROTEIN; PROTEIN; PROTEIN S 100; RIBOSOME PROTEIN; STRATUM CORNEUM CHYMOTRYPTIC ENZYME; TRYPTOPHAN 5 MONOXYGENASE ACTIVATION PROTEIN; TRYPTOPHAN HYDROXYLASE; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL COMMUNICATION; CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CELL INTERACTION; CELL PROLIFERATION; CLINICAL ARTICLE; COCULTURE; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; ENZYME ACTIVATION; EPITHELIUM CELL; FIBROBLAST; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MALE; MOLECULAR CLONING; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; PHASE CONTRAST MICROSCOPY; PRIORITY JOURNAL; PROSTATE DISEASE; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; PROSTATECTOMY; PROTEIN CONTENT; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; RNA SEQUENCE; STROMA CELL; UPREGULATION; WESTERN BLOTTING;

14-3-3 PROTEINS; ANTIGENS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL COMMUNICATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CYCLIN I; DOWN-REGULATION; EPITHELIAL CELLS; FIBROBLASTS; GENE EXPRESSION PROFILING; HUMANS; KALLIKREINS; MALE; PROSTATIC HYPERPLASIA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; S100 PROTEINS; UP-REGULATION;

EID: 77954709194     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm-00000429     Document Type: Article

References (26)

1. Roehrborn CG and McConnell JD: Benign prostatic hyperplasia. In: Campbell's Urology. Walsh PC, Retik AB, Vaughan ED and Wein AJ (eds). 8th edition. Saunders, Philadelphia, p1297, 2002.
2. Ma QJ, Gu XQ, Cao X, Zhao J, Kong XB, Li YX and Cai SY: Effect of beta radiation on TGF-ß1 and ßFGF expression in hyperplastic prostatic tissues. Asian J Androl 7: 49-54, 2005.
3. Cunha GR, Hayward SW, Dahiya R and Foster BA: Smooth muscle-epithelial interactions in normal and neoplastic prostatic development. Acta Anat 155: 63-72, 1996. (Pubitemid 26193060)
4. Kooistra A, Konig JJ, Keizer DM, Romijn JC and Schroder FH: Inhibition of prostatic epithelial cell proliferation by a factor secreted specifically by prostatic stromal cells. Prostate 26: 123-132, 1995.
5. Stamatiou K, Alevizos A, Natzar M, Mihas C, Mariolis A and Michalodimitrakis E: Associations among benign prostate hypertrophy, atypical adenomatous hyperplasia and latent carcinoma of the prostate. Asian J Androl 9: 229-233, 2007.
6. Bayne CW, Donnelly F, Chapman K, Bollina P, Buck C and Habib F: A novel coculture model for benign prostatic hyperplasia expressing both isoforms of 5 α-reductase. J Clin Endocrinol Metab 83: 206-213, 1998.
7. Habib FK: Regulation of prostate growth in culture with the pollen extract, cernitin T-60 and the impact of the drug on the EGF tissue profiles. In: Benign Prostate Diseases. Vahlensieck W and Rutishauser G (eds). Stuttgart, Thieme Verlag, New York, pp120-128, 1992.
8. Bayne CW, Ross M, Donnelly F, Chapman K, Buck C and Bollina P: Selective interactions between prostate fibroblast and epithelial cells in co-culture maintain the BPH phenotype. Urol Int 61: 1-7, 1998.
9. Egelrud T: Purification and preliminary characterization of stratum corneum chymotryptic enzyme: a proteinase that may be involved in desquamation. J Invest Dermatol 101: 200-204, 1993.
10. Hansson L, Stromqvist M, Backman A, Wallbrandt P, Carlstein A and Egelrud T: Cloning, expression, and characterization of stratum corneum chymotryptic enzyme. A skin-specific human serine proteinase. J Biol Chem 269: 19420-19426, 1994.
11. Dong Y, Kaushal A, Brattsand M, Nicklin J and Clements JA: Differential splicing of KLK5 and KLK7 in epithelial ovarian cancer produces novel variants with potential as cancer biomarkers. Clin Cancer Res 9: 1710-1720, 2003.
12. Borgono CA and Diamandis EP: The emerging roles of human tissue kallikreins in cancer. Nat Rev Cancer 4: 876-890, 2004.
13. Planque C, de Monte M, Guyetant S, Rollin J, Desmazes C and Panel V: KLK5 and KLK7, two members of the human tissue kallikrein family, are differentially expressed in lung cancer. Biochem Biophys Res Commun 329: 1260-1266, 2005.
14. Kyriakopoulou LG, Yousef GM, Scorilas A, Katsaros D, Massobrio M and Fracchioli S: Prognostic value of quantitatively assessed KLK7 expression in ovarian cancer. Clin Biochem 36: 135-143, 2003. (Pubitemid 36287493)
15. Talieri M, Diamandis EP, Gourgiotis D, Mathioudaki K and Scorilas A: Expression analysis of the human kallikrein 7 (KLK7) in breast tumors: a new potential biomarker for prognosis of breast carcinoma. Thromb Haemos 91: 180-186, 2004. (Pubitemid 38111235)
16. Magklara A, Scorilas A, Stephan C, Kristiansen GO, Hauptmann S and Jung K: Decreased concentrations of prostate-specific antigen and human glandular kallikrein 2 in malignant versus nonmalignant prostatic tissue. Urology 56: 527-532, 2000.
17. Yousef GM, Scorilas A, Magklara A, Soosaipillai A and Diamandis EP: The KLK7 (PRSS6) gene, encoding for the stratum corneum chymotryptic enzyme is a new member of the human kallikrein gene family - genomic characterization, mapping, tissue expression and hormonal regulation. Gene 254: 119-128, 2000.
18. Yousef GM, Polymeris ME, Yacoub GM, Scorilas A, Soosaipillai A and Popalis C: Parallel overexpression of seven kallikrein genes in ovarian cancer. Cancer Res 63: 2223-2227, 2003.
19. Makino E, Sakaguchi M, Iwatsuki K and Huh NH: Introduction of an N-terminal peptide of S100C/A11 into human cells induces apoptotic cell death. J Mol Med 82: 612-620, 2004.
20. Sakaguchi M, Miyazaki M, Inoue Y, Tsuji T, Kouchi H and Tanaka T: Relationship between contact inhibition and intra-nuclear S100C of normal human fibroblasts. J Cell Biol 149: 1193-1206, 2000.
21. Seth A, Kitching R, Landberg G, Xu J, Zubovits J and Burger AM: Gene expression profiling of ductal carcinomas in situ and invasive breast tumors. Anticancer Res 23: 2043-2051, 2003.
22. Landberg G, Nilsson K, Jirström K, Rydén L, Kitching R and Burger AM: Cyclin I is expressed in human breast cancer and closely associated with VEGF and KDR expression. Breast Cancer Res Treat 89: 313-316, 2005.
23. Sun ZL, Zhu Y, Wang FQ, Chen R, Peng T, Fan ZN, Xu ZK and Miao Y: Serum proteomic-based analysis of pancreatic carcinoma for the identification of potential cancer biomarkers. Biochim Biophys Acta 1774: 764-771, 2007.
24. Bolduc C, Larose M, Yoshioka M, Ye P, Belleau P and Labrie C: Effects of dihydrotestosterone on adipose tissue measured by serial analysis of gene expression. J Mol Endocrinol 33: 429-444, 2004.
25. Cavet ME, Lehoux S and Berk BC: 14-3-3β is a p90 ribosomal S6 kinase (RSK) isoform 1-binding protein that negatively regulates RSK kinase activity. J Biol Chem 278: 18376-18383, 2003.
26. Liang Y, Jansen M, Aronow B, Geiger H and Van Zant G: The quantitative trait gene latexin influences the size of the hematopoietic stem cell population in mice. Nat Genet 39: 178-188, 2007.